A Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients with Recurrent Ovarian Cancer
Trial Number
NCT04742075 (ClinicalTrials.gov Identifier)Contact Person
Status
Recruiting
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
BGOG
CEEGOG
DGOG
NOGGO